In the BEACON study, patients receiving the higher 45 mg dose of brepocitinib saw substantial reductions in skin disease ...

Anavex Life Sciences (AVXL) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one ...

Abbott made a takeover offer for Exact Sciences. The two companies want to team up to combat cancer. Under the terms of the deal, Exact Sciences' stockholders would receive $105 per share in cash. The ...

Gilead's revenue is anchored by Biktarvy, protected by exclusivity through 2036, reducing near-term patent cliff risk vs. peers. Learn more about GILD stock here.

Exact Sciences' most important product is driving solid revenue growth. It has launched several others that could help boost sales and jolt the stock. The company's long-term prospects look attractive ...

Achieve Life Sciences is a late-stage pharma company awaiting FDA approval for Cytisinicline, a novel smoking cessation ...

Gilead Sciences Inc. stock reached an all-time high of $153.32, marking a significant milestone for the biopharmaceutical company. Over the past year, Gilead’s stock has deliver ...

Investing.com -- STRATA Skin Sciences Inc (NASDAQ:SSKN) stock plummeted 60.8% in premarket trading Thursday after the company announced it would be delisted from the Nasdaq Capital Market due to ...

Wave Life Sciences Ltd. (NASDAQ:WVE) stock is trading lower on Wednesday after the company shared data from the ongoing Phase 1b/2a RestorAATion-2 Trial of WVE-006 in alpha-1 antitrypsin deficiency.